Qihoo 360 has contributed to a $13.2m series B round that will help Profusa commercialise its biosensor technology, which monitors body chemistry.
US-based biotechnology company Profusa has raised $13.2m in series B funding from investors including cybersecuirty company Qihoo 360.
The round was co-led by venture capital firms 3E Bioventures and Asset Management Ventures, and also featured existing, unnamed series A shareholders.
Joan Braddi, vice-president of global product partnerships at internet technology producer Google and Karen Liu, managing partner at 3E Bioventures, have joined Profusa’s board of directors. Google does not appear to have invested in the round, however.
Founded in 2009,…
